Preferred Label : neisseria meningitidis, serogroup a;

MeSH definition : Strains of Neisseria meningitidis responsible for most outbreaks of meningococcal disease in Western Europe and the United States in the first half of the 20th century. They continue to be a major cause of disease in Asia and Africa, and especially localized epidemics in Sub-Sahara Africa.;

MeSH synonym : meningococci, serogroup a; meningococcus, serogroup a;

MeSH annotation : infection: coord IM with MENINGITIS, MENINGOCOCCAL (IM) or, if not meningitis, MENINGOCOCCAL INFECTIONS (IM);

UNII : txid65699;

Details


Main resources

You can consult :

Strains of Neisseria meningitidis responsible for most outbreaks of meningococcal disease in Western Europe and the United States in the first half of the 20th century. They continue to be a major cause of disease in Asia and Africa, and especially localized epidemics in Sub-Sahara Africa.

http://www.has-sante.fr/portail/jcms/c_2041961/fr/nimenrix-vaccins-meningococciques-a-c-w135-et-y-conjugues
http://www.has-sante.fr/portail/jcms/c_2041961/fr/nimenrix
2015
false
France
French
tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine
tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine
guidelines for drug use
meningitis, meningococcal
antibiotic therapy
evaluation of the transparency committee
insurance, health, reimbursement
vaccination
injections, intramuscular
meningococcal infections
neisseria meningitidis, serogroup a
vaccines, conjugate
neisseria meningitidis, serogroup C
neisseria meningitidis, serogroup W-135
neisseria meningitidis, serogroup y
meningococcal vaccines
meningococcal vaccines
polysaccharides, bacterial
tetanus toxoid
meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen conjugated
risk factors
infant
immunization schedule
immunization, secondary
drug interactions
child
adult
adolescent
treatment outcome
clinical trials, phase iii as topic
adaptive immunity

---
http://www.cochrane.org/fr/CD001093
2012
United Kingdom
France
French
antibiotic therapy
meta-analysis
meningitis, meningococcal
meningococcal vaccines
treatment outcome
child
neisseria meningitidis, serogroup a
french abstract

---
http://www.has-sante.fr/portail/jcms/c_1352587/nimenrix
http://www.has-sante.fr/portail/upload/docs/evamed/CT-12514_NIMENRIX_Insc_AVIS2_CT12514.pdf
2012
false
France
French
tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine
tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine
antibiotic therapy
evaluation of the transparency committee
insurance, health, reimbursement
vaccination
injections, intramuscular
meningococcal infections
neisseria meningitidis, serogroup a
vaccines, conjugate
neisseria meningitidis, serogroup C
neisseria meningitidis, serogroup W-135
neisseria meningitidis, serogroup y
meningococcal vaccines
meningococcal vaccines
polysaccharides, bacterial
tetanus toxoid
meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen conjugated
risk factors
infant
immunization schedule
immunization, secondary
drug interactions
child
adult
adolescent
treatment outcome
clinical trials, phase iii as topic
adaptive immunity

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=61920725
2009
France
French
antibiotic therapy
polysaccharides, bacterial
meningococcal vaccines
vaccination
neisseria meningitidis, serogroup a
neisseria meningitidis, serogroup C
meningococcus A,C, bivalent purified polysaccharides antigen
adult
child
meningitis, meningococcal
meningococcal infections
injections, intramuscular
injections, subcutaneous
meningococcal vaccines
summary of product characteristics
package leaflet

---
Nous contacter.
26/04/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.